PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14693716-9	2004	Dominant-negative PPAR-gamma (Delta PPAR-gamma) completely abrogated the inhibitory effect of pioglitazone and incompletely blocked its effect of 15d-PGJ(2) on TGF-beta 1-induced AP-1 reporter activity.	15d-pgj	146-153	peroxisome proliferator activated receptor gamma	Mus musculus	18-28	
22192475-0	2012	PPAR-gamma agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge.	15d-pgj	28-35	peroxisome proliferator activated receptor gamma	Mus musculus	0-10	
22192475-1	2012	We evaluate the immunomodulation of Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists 15d-PGJ(2) and rosiglitazone (RGZ) in a model of chronic eosinophilia.	15d-pgj	107-114	peroxisome proliferator activated receptor gamma	Mus musculus	36-84	
20854809-7	2011	Furthermore, TSIIA reduced the mRNA expression of CD36 in macrophages treated with PPARgamma agonist 15d-PGJ(2) (2muM) or troglitazone (50muM), whereas both 15d-PGJ(2) (0.5-1.5muM) and troglitazone (5-20muM) dose-dependently abolished the down-regulation of CD36 expression by TSIIA in oxLDL treated macrophages.	15d-pgj	101-108	peroxisome proliferator activated receptor gamma	Mus musculus	83-92	
20019843-1	2009	15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)), a peroxisome proliferator-activated receptor gamma (PPARgamma) agonist, induces cell death in tumor cells in vitro; however, no study showed its in vivo effect on tumors.	15d-pgj	42-49	peroxisome proliferator activated receptor gamma	Mus musculus	57-105	
20019843-1	2009	15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)), a peroxisome proliferator-activated receptor gamma (PPARgamma) agonist, induces cell death in tumor cells in vitro; however, no study showed its in vivo effect on tumors.	15d-pgj	42-49	peroxisome proliferator activated receptor gamma	Mus musculus	107-116	
18208815-9	2008	Moreover, 15d-PGJ(2) induced both PPARalpha and PPARgamma activation.	15d-pgj	10-17	peroxisome proliferator activated receptor gamma	Mus musculus	48-57	
17130903-9	2007	These results suggest that the synergistic effect of 15d-PGJ(2) on LPS-induced MIP-2 (CXCL2) expression is PPARgamma-independent, and is mediated by the p38 and SAPK/JNK pathway in mitogen-activated protein kinase signaling pathways, which activates NF-kappaB.	15d-pgj	53-60	peroxisome proliferator activated receptor gamma	Mus musculus	107-116	
22219346-9	2012	Interestingly, pretreatment of mice with a peroxisome proliferator-activated receptor gamma (PPARgamma) antagonist before 15d-PGJ(2) administration completely abrogated its protective effect against influenza infection.	15d-pgj	122-129	peroxisome proliferator activated receptor gamma	Mus musculus	43-91	
22219346-9	2012	Interestingly, pretreatment of mice with a peroxisome proliferator-activated receptor gamma (PPARgamma) antagonist before 15d-PGJ(2) administration completely abrogated its protective effect against influenza infection.	15d-pgj	122-129	peroxisome proliferator activated receptor gamma	Mus musculus	93-102	
22192475-1	2012	We evaluate the immunomodulation of Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists 15d-PGJ(2) and rosiglitazone (RGZ) in a model of chronic eosinophilia.	15d-pgj	107-114	peroxisome proliferator activated receptor gamma	Mus musculus	86-96	
21924248-5	2011	Knockdown of peroxisome proliferator-activated receptor-gamma (PPARgamma) with siRNA abolished pioglitazone- and 15d-PGJ(2)-induced VLDLR expression and simultaneously reduced VLDL uptake in adipocytes.	15d-pgj	113-120	peroxisome proliferator activated receptor gamma	Mus musculus	13-61	
21924248-5	2011	Knockdown of peroxisome proliferator-activated receptor-gamma (PPARgamma) with siRNA abolished pioglitazone- and 15d-PGJ(2)-induced VLDLR expression and simultaneously reduced VLDL uptake in adipocytes.	15d-pgj	113-120	peroxisome proliferator activated receptor gamma	Mus musculus	63-72	
21924248-8	2011	Sequence analysis revealed the presence of a putative PPARgamma responsive sequence (PPRE) within the vldlr promoter, which is responsive to natural (15d-PGJ(2)) and synthetic (pioglitazone) PPARgamma agonists.	15d-pgj	150-157	peroxisome proliferator activated receptor gamma	Mus musculus	54-63	
14693716-9	2004	Dominant-negative PPAR-gamma (Delta PPAR-gamma) completely abrogated the inhibitory effect of pioglitazone and incompletely blocked its effect of 15d-PGJ(2) on TGF-beta 1-induced AP-1 reporter activity.	15d-pgj	146-153	peroxisome proliferator activated receptor gamma	Mus musculus	36-46